IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised AELIS FARMA with a team including Joseph Marx (Equity Capital Markets), […]
Aelis Farma’s IPO on Euronext Paris
Meiogenix’s $13 Million Series A Financing Round
McDermott Will & Emery advised Meiogenix on the round. Meiogenix announced the closing of a USD 13 million (EUR 11 million) Series A financing round led […]
Corteria Pharmaceuticals’ €12 Million Financing Round
McDermott Will & Emery advised Corteria Pharmaceuticals on the deal. Corteria Pharmaceuticals, a French biotechnology company specializing in the development of interceptive therapies for heart failure […]
Egle Therapeutics’ €40 Million Series A Funding Round
McDermott Will & Emery advised Egle Therapeutics on the deal. Gide advised the pool of investors, while Morgan, Lewis & Bockius advised Takeda Ventures. Egle Therapeutics, […]